BLMH Antibody
Product Specifications
Background
Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily.
NCBI Gene ID
642
Swiss Prot
Q13867
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 1-300 of human BLMH (NP_000377.1) .
Clonality
Polyclonal
Conjugation
Unconjugated
Type
Primary Antibodies
Field of Research
Cell Cycle, Neuroscience
Purification
Affinity purification
Positive Control
NCI-H460
Concentration
Batch dependent
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Store at -20˚ C. Avoid freeze / thaw cycles.
Calculated Molecular Weight
Observed: 50kDa
Fragment
IgG
Symbol
BLMH
Positive Control 2
Rat thymus
NCBI Official Name
Bleomycin hydrolase
NCBI Organism
Homo sapiens
Other Product Names
Bleomycin hydrolase, BH, BLM hydrolase, BMH, BLMH
Tested Applications
WB, IHC, IF
Physical Properties
Liquid
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1007138-01 0.02 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype IB Succinyl-diaminopimelate desuccinylase (dapE)
Ask
View Details MBS1007138-02 0.02 mg (Yeast)
Recombinant Yersinia pseudotuberculosis serotype IB Succinyl-diaminopimelate desuccinylase (dapE)
Ask
View Details MBS1007138-03 0.1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype IB Succinyl-diaminopimelate desuccinylase (dapE)
Ask
View Details 
MBS1007138-04 0.1 mg (Yeast)
Recombinant Yersinia pseudotuberculosis serotype IB Succinyl-diaminopimelate desuccinylase (dapE)
Ask
View Details